Entries by Maren Kühr

Biomunex appoints new CSO

The biopharmaceutical company Biomunex Pharmaceuticals announces the appointment of Dr Simon Plyte as Chief Scientific Officer (CSO) and as a member of its scientific advisory board.

Highly pure DNA from tissue in just 50 minutes

The EchoLUTION Tissue DNA Kit from BioEcho was developed to isolate high-quality DNA in a short time, even from difficult-to-extract samples such as muscle and adipose tissue. Due to the significantly shorter lysis and reduced number of steps, the entire workflow is three to ten times faster than conventional methods that follow the bind-wash-elute principle.

International expertise returns to Belgium

VIB and Flemish Minister of Economy and Innovation, Hilde Crevits, announce the appointment of Dr Christine Durinx as VIB’s co-managing director, alongside Dr Jérôme Van Biervliet. Dr Jo Bury, co-founder and co-managing director since VIB’s inception 25 years ago, is passing the torch to Durinx who is the former Executive Director of the SIB Swiss Institute of Bioinformatics.

IZB start-up AMSilk GmbH

Building a sustainable future this is what drives us. We are passionate about making smart biotech materials part of everyday life. We believe nature offers better alternatives to existing materials with biofabricated technologies previously unimaginable – enabling our customers to make a true change. 

After the setback, what's next for biotech stocks?

While the Nasdaq Biotechnology index saw a huge uplift during the pandemic (+ 77% since March 2020 until reaching a peak in August 2021), it lost 27% during the last six months vs a 11%/4% decline for the Nasdaq Composite and the S&P 500, respectively

Automated workflow

The SARS-CoV-2 virus global outbreak generated a need for fast and reliable large-scale testing. One of the main bottlenecks of the PCR test is the laborious and time-consuming molecular method for viral genetic material extraction. BioEcho Life Sciences, together with Hamilton and the German diagnostics laboratory ‘Labor Dr. Fenner und Kollegen’ developed an automated workflow for 96- and 48-well plate formats.

Lasers to personalise therapy

Biotechnology is a key market segment for Coherent. We provide innovative solutions for academic research, pharma discovery, translational research, clinical testing, and interventional therapeutics. We support these applications with lasers, laser engines, fibers, and fiber optic components.

Austria magnet for biotechnology

The life sciences location of Austria has gained considerable momentum since the ­founding of the very first Austrian biotech company Intercell at the turn of the millennium. Today the who’s who of the biotech sector relies on Austria, in particular on its capital city of Vienna.